High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus-Reference-Cited by-同舟云学术

High Mobility Group Box 1: a potential therapeutic target for systemic lupus erythematosus

Published:2009-02-27 Issue:3 Volume:37 Page:1191-1195
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Pan Hai-Feng,Wu Guo-Cui,Li Wei-Ping,Li Xiang-Pei,Ye Dong-Qing

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-009-9485-7.pdf

Reference44 articles.

1. Pan HF, Ye DQ, Li XP (2008) Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol 4:352–353

2. Pan HF, Fang XH, Li WX et al (2008) Radix astragali: a promising new treatment option for systemic lupus erythematosus. Med Hypotheses 71:311–312. doi: 10.1016/j.mehy.2008.03.011

3. Cook HT, Botto M (2006) Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:330–337. doi: 10.1038/ncprheum0191

4. Voll RE, Urbonaviciute V, Herrmann M et al (2008) High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Isr Med Assoc J 10:26–28

5. Jiang W, Pisetsky DS (2008) Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis 67:727–728. doi: 10.1136/ard.2007.074484

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KLHDC7B as a Potential Therapeutic Target in Systemic Lupus Erythematosus: Insights from Bulk and Single-Cell RNA-Seq and Spatial Transcriptomics of Epidermal Keratinocytes;2024-08-02

2. Neural Regeneration in Dry Eye Secondary to Systemic Lupus Erythematosus Is Also Disrupted like in Rheumatoid Arthritis, but in a Progressive Fashion;International Journal of Molecular Sciences;2023-06-26

3. HMGB1 in kidney diseases;Life Sciences;2020-10

Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis

;International Journal of Nanomedicine;2019-11

5. Neutrophil extracellular traps are a source of extracellular HMGB1 in lupus nephritis: associations with clinical and histopathological features;Lupus;2019-10-16